Commercialization Considerations for Individualized Diagnostic and Drug Therapies Resulting from Pharmacogenomics

› ›

Author: Jeffrey L. Moe

Position: Ph.D., Executive in Residence & Senior Director Business Development

Pages: 103-116

Linked as:


Document options

Extract

Commercialization Considerations for Individualized Diagnostic and Drug Therapies Resulting from Pharmacogenomics

No longer available (Autolink)

See the full content of this document